Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. März 2025 08:31 ET | Quelle: Genelux Corporation

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an...
24. Mai 2024 08:00 ET | Quelle: Genelux Corporation

Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants

Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
23. Mai 2024 16:01 ET | Quelle: Genelux Corporation

Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants

Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
12. Juni 2023 07:00 ET | Quelle: Genelux Corporation

Genelux Corporation Announces $18 Million Private Placement

WESTLAKE VILLAGE, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced a private placement for 900,000 shares...
15. Mai 2023 07:00 ET | Quelle: Genelux Corporation

Genelux Corporation Announces $33 Million Private Placement

WESTLAKE VILLAGE, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced a private placement of 1,665,247 shares...